AR - androgen receptor Gene

Also Known as NR3C4

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 102117720

About AR

Primary_assembly X: 61,251,587-61,415,611 forward strand.Macaca_fascicularis_6.0:CM021959.1

This gene has 2 transcripts (splice variants), 276 orthologues and 7 paralogues.

AR Products (2)

mRNA Protein Name
XM_005593810.3 XP_005593867.1 androgen receptor isoform X1
XM_045384269.1 XP_045240204.1 androgen receptor isoform X2

AR Protein Structure

Androgen_recep

Androgen_recep: pfam02166 (5 - 431)

NR_DBD_AR

NR_DBD_AR: cd07173 (529 - 610)

NR_LBD_AR

NR_LBD_AR: cd07073 (647 - 892)

  • 0
  • 200
  • 400
  • 600
  • 800
  • 895 a.a.
Protein Preferred Names Protein Names

androgen receptor

  • Dihydrotestosterone receptor

  • Nuclear receptor subfamily 3 group C member 4

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (65)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-70002 Enzalutamide 99.97% Unkown
HY-13715 Norepinephrine 99.61% Unkown
HY-B0573B Propranolol Antagonist 99.91% Yes
HY-B0573 Propranolol hydrochloride Antagonist 99.95% Yes
HY-N0378 D-Mannitol 99.93% Yes
HY-Y1269 Ammonium chloride, AR, 99.5% Inhibitor 99.69% Yes
HY-111372 Finerenone Antagonist 99.91% Unkown
HY-10064 Ticagrelor Antagonist 99.95% Yes
HY-N0092 Inosine Agonist 99.94% Yes
HY-13715A Norepinephrine hydrochloride 99.95% Yes
HY-16985 Darolutamide Antagonist 99.49% Unkown
HY-14249 Bicalutamide 99.92% Unkown
HY-16060 Apalutamide Antagonist 99.94% Unkown
HY-17627 Avacopan Inhibitor 98.50% Yes
HY-B1037 Salbutamol 99.96% Yes
HY-13715B Norepinephrine bitartrate monohydrate 99.96% Unkown
HY-13613 Dutasteride 98.81% Yes
HY-19638A Cangrelor tetrasodium Antagonist 99.96% Unkown
HY-15746 Dobutamine hydrochloride Agonist 99.60% Yes
HY-17042 Cetirizine Antagonist 99.79% Yes
HY-10122 Silodosin Antagonist 99.89% Yes
HY-12798 Netarsudil Inhibitor 99.94% Unkown
HY-108449 Acoltremon Agonist 99.13% Unkown
HY-N0138 Theobromine Inhibitor 99.55% Unkown
HY-14300A Vilanterol trifenatate Agonist 99.82% Unkown
HY-17497A Acebutolol hydrochloride Antagonist 99.70% Unkown
HY-B0436 Salbutamol hemisulfate 98.0% Yes
HY-12798B Netarsudil hydrochloride Inhibitor 99.90% Unkown
HY-13715R Norepinephrine (Standard) 99.97% Unkown
HY-B0111 Drospirenone Agonist 99.95% Unkown
HY-17042A Cetirizine dihydrochloride Antagonist 99.58% Yes
HY-14301 Olodaterol Agonist 99.85% Unkown
HY-B0659 Brimonidine Agonist 99.98% Yes
HY-13715C Norepinephrine tartrate 99.96% Unkown
HY-B0659A Brimonidine tartrate Agonist 99.68% Yes
HY-15746A Dobutamine Agonist 98.75% Yes
HY-B1114 Gliquidone Inhibitor 99.93% Unkown
HY-12798A Netarsudil dimesylate 99.90% Unkown
HY-14300 Vilanterol Agonist 99.30% Unkown
HY-B1486 Oxprenolol hydrochloride Antagonist 99.86% Unkown
HY-14301A Olodaterol hydrochloride Agonist 99.70% Unkown
HY-B1276 Metaproterenol hemisulfate Agonist 99.44% Unkown
HY-70002B Enzalutamide carboxylic acid 98.60% Unkown
HY-A0295 (R)-Propranolol hydrochloride Antagonist 99.32% Unkown
HY-B1470 Azaperone Antagonist 99.23% Unkown
HY-B0004 Doxofylline 99.97% Yes
HY-B0010D Arformoterol tartrate Agonist 99.63% Unkown
HY-B1037R Salbutamol (Standard) 99.91% Unkown
HY-U00205 Dopexamine hydrochloride Agonist 98.04% Unkown
HY-B0010A Arformoterol Agonist 99.96% Unkown
HY-B1016 Trapidil Inhibitor 98.0% Unkown
HY-17497 Acebutolol Antagonist 99.70% Unkown
HY-B0659S Brimonidine-d4 Agonist 99.13% Unkown
HY-B0484 Buflomedil hydrochloride Antagonist 99.86% Unkown
HY-15746B Dobutamine tartrate Agonist / Unkown
HY-19638 Cangrelor Antagonist / Unkown
HY-13613R Dutasteride (Standard) / Unkown
HY-B0484A Buflomedil Antagonist / Unkown
HY-B1016R Trapidil (Standard) Inhibitor / Unkown
HY-B1276A Metaproterenol Agonist / Unkown
HY-B1486A Oxprenolol Antagonist / Unkown
HY-B1562 Bopindolol / Unkown
HY-12502AR Efonidipine hydrochloride monoethanolate (Standard) Inhibitor / Unkown
HY-B0010E Arformoterol maleate Agonist / Unkown
HY-B1470R Azaperone (Standard) Antagonist / Unkown

Clinical Phase

Bioactive Molecules (61)
Cat. No. Product Name Effect
Purity Phase
HY-15758 3,3'-Diindolylmethane 99.89% Phase 4
HY-N0378R D-Mannitol (Standard) 99.96% Phase 4
HY-12023 GTx-007 Modulator 99.61% Phase 4
HY-106827 Trimegestone / Phase 4
HY-159686 Aclidinium Agonist / Phase 4
HY-10211 Tanespimycin 99.01% Phase 3
HY-158101 BMS-986365 Degrader 99.92% Phase 3
HY-13591 Piclidenoson 99.01% Phase 3
HY-12365 Namodenoson Agonist 99.56% Phase 3
HY-50289 Sorbinil Inhibitor 99.85% Phase 3
HY-70006 Galeterone 99.87% Phase 3
HY-15314 Ranirestat Inhibitor 96.10% Phase 3
HY-101479 Iclaprim Inhibitor 98.92% Phase 3
HY-18967 Caficrestat Inhibitor 99.74% Phase 3
HY-70002S Deutenzalutamide 99.80% Phase 3
HY-14561 Idazoxan / Phase 3
HY-135487 Sibenadet Agonist / Phase 3
HY-105122 Zanoterone Antagonist / Phase 3
HY-111784 Inobrodib Inhibitor 99.95% Phase 2
HY-138641 Bavdegalutamide Inhibitor 99.64% Phase 2
HY-153342 Luxdegalutamide Degrader 98.99% Phase 2
HY-106178 PMX-53 Antagonist 99.95% Phase 2
HY-101978 Ciforadenant Antagonist 99.92% Phase 2
HY-129393 Etrumadenant Antagonist 99.64% Phase 2
HY-101980 Imaradenant Antagonist 99.68% Phase 2
HY-100186 GSK-2881078 Modulator 99.42% Phase 2
HY-111151 AR-9281 Inhibitor 99.69% Phase 2
HY-11027 MK-0773 Inhibitor 99.92% Phase 2
HY-19687 Zopolrestat Inhibitor 99.92% Phase 2
HY-115282A JNJ-63576253 Antagonist 99.20% Phase 2
HY-109139 Taminadenant Antagonist 99.84% Phase 2
HY-123875A Ralaniten triacetate Inhibitor 99.89% Phase 2
HY-15996 Seviteronel 99.83% Phase 2
HY-111024 2,2,5,7,8-Pentamethyl-6-Chromanol 99.30% Phase 2
HY-19436 Solabegron Agonist 99.89% Phase 2
HY-106954 Upidosin Antagonist 99.48% Phase 2
HY-106303 YT 146 Agonist 99.72% Phase 2
HY-16055 Silatecan Inhibitor 96.62% Phase 2
HY-101555 M 16209 Inhibitor / Phase 2
HY-10273 Atecegatran metoxil Inhibitor / Phase 2
HY-106186 GW-493838 Agonist / Phase 2
HY-106388 Fadolmidine Agonist / Phase 2
HY-12172 MK-8141 Inhibitor / Phase 2
HY-124742 AR-HO47108 Inhibitor / Phase 2
HY-14897 Rezatomidine Agonist / Phase 2
HY-16741 Erlosiban Antagonist / Phase 2
HY-16758A Verosudil hydrochloride Inhibitor / Phase 2
HY-182783 JNJ-10450232 Agonist / Phase 2
HY-19885 AR-102 Inhibitor / Phase 2
HY-U00371 AR-08 Agonist / Phase 2
HY-10547 OSU-03012 99.80% Phase 1
HY-103169 SCH442416 Antagonist 99.94% Phase 1
HY-13265 AR-42 Inducer 98.52% Phase 1
HY-112052 Aminomalonic acid 99.97% Phase 1
HY-12798C AR-13503 Inhibitor 98.21% Phase 1
HY-16079 AZD3514 Inhibitor 99.65% Phase 1
HY-156751A GDC-2992 Degrader 99.38% Phase 1
HY-125639 (rac)-AR-13503 Inhibitor 99.08% Phase 1
HY-148954 PBF-999 Antagonist 98.89% Phase 1
HY-177670 Zintevir Inhibitor / Phase 1
HY-157472 ACT-1014-6470 Antagonist / Phase 1
Inhibitory Antibodies (4)
Cat. No. Product Name Effect
Purity Phase
HY-P99551 Tosatoxumab 95.00% Phase 3
HY-P99450 Avdoralimab Inhibitor 99.25% Phase 2
HY-P991493 AR-201 Inhibitor / Phase 2
HY-P990745 Izastobart Ligand 99% Phase 1

Pre-clinical Phase

Bioactive Molecules (755)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-153169 6PPD-Q Inhibitor 99.77% Unkown
HY-145388 AU-15330 Degrader 99.89% Unkown
HY-13248 AR-C155858 Inhibitor 99.77% Unkown
HY-19532 ZM241385 Antagonist 99.45% Unkown
HY-W187305 MASM7 99.85% Unkown
HY-100543 Zenidolol 99.60% Unkown
HY-135794 11-Ketodihydrotestosterone Agonist 99.87% Unkown
HY-101106 AR7 Antagonist 99.38% Unkown
HY-134923 CA77.1 Inducer 99.92% Unkown
HY-138161 JR14a Antagonist 99.77% Unkown
HY-W093399 Ammonium bicarbonate,AR,99% Inhibitor 99.0% Unkown
HY-110136A PMX 205 Trifluoroacetate Antagonist 99.50% Unkown
HY-Y0537 Potassium chloride, AR, 99.5% 99.6% Unkown
HY-10512 AR-A014418 Inhibitor 99.21% Unkown
HY-12111 BMS-564929 Agonist 98.28% Unkown
HY-N0236 Corylin Inhibitor 99.97% Unkown
HY-110126 AR-C118925XX Antagonist ≥99.0% Unkown
HY-N0790 Lupeol 98.0% Unkown
HY-131498 Mca-PLGL-Dpa-AR-NH2 Substrate 99.86% Unkown
HY-N1943 Ailanthone Inhibitor 99.93% Unkown
HY-P4931 Mca-KPLGL-Dap(Dnp)-AR-NH2 99.30% Unkown
HY-101986 BIIE-0246 Antagonist 99.10% Unkown
HY-W015061 Phenylacetylglycine 99.38% Unkown
HY-158113 CBPD-409 Degrader 99.38% Unkown
HY-Y0332B Potassium dihydrogen phosphate, AR,99.5% Activator 99.7% Unkown
HY-N2037 Higenamine 99.31% Unkown
HY-W011927 4,4'-Sulfonyldiphenol 99.81% Unkown
HY-110136 PMX 205 Antagonist 99.95% Unkown
HY-116522 AR420626 98.40% Unkown
HY-N0166 Gramine 99.80% Unkown
HY-130492 ARCC-4 Inhibitor 99.88% Unkown
HY-N0092S2 Inosine-13C5 Agonist 99.90% Unkown
HY-153918 (R)-SKBG-1 Inhibitor 99.68% Unkown
HY-121251 BI-167107 Agonist 99.61% Unkown
HY-176521 AR/BRD4 RIPTAC-1 98.65% Unkown
HY-13981 Ligandrol 99.93% Unkown
HY-19334 L755507 Agonist 98.89% Unkown
HY-Y0261A Ammonium sulphate,≥99.0%,AR 99.30% Unkown
HY-149433 BWA-522 98.04% Unkown
HY-N0819 Raddeanin A 98.68% Unkown
HY-148141 JPE-1375 Antagonist 99.96% Unkown
HY-P1345A TLQP-21 TFA Agonist 99.90% Unkown
HY-114936 Piericidin A Inhibitor 99.83% Unkown
HY-148771 MTX-23 99.79% Unkown
HY-173626 EN1441 Degrader 99.67% Unkown
HY-78055 2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol 99.76% Unkown
HY-145479 PROTAC AR-V7 degrader-1 Degrader 98.19% Unkown
HY-100554 BMY 7378 99.94% Unkown
HY-15564 AR 231453 Agonist 99.58% Unkown
HY-161409 SC912 99.13% Unkown
HY-B0845 Prochloraz 99.85% Unkown
HY-145237 BM213 99.62% Unkown
HY-110012 SCH-202676 hydrobromide Modulator 98.85% Unkown
HY-116501 VPC-14449 Inhibitor 99.51% Unkown
HY-30756 tert-Butyl 2,7-diazaspiro[3.5]nonane-2-carboxylate 99.89% Unkown
HY-W250160 PDRN 90.20% Unkown
HY-103190 MRS1220 Antagonist 99.52% Unkown
HY-124292 Honokiol DCA Inhibitor 98.01% Unkown
HY-169841 IHCH-7086 Agonist 98.96% Unkown
HY-173634 Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan Inhibitor 99.95% Unkown
HY-161369 CBPD-268 Degrader 99.23% Unkown
HY-123012 Lubabegron Modulator 98.40% Unkown
HY-150102 EPI-7170 Antagonist 99.86% Unkown
HY-153152 DPTN dihydrochloride Antagonist 98.47% Unkown
HY-100348 EPI-001 99.34% Unkown
HY-W011927S 4,4'-Sulfonyldiphenol-d8 99.21% Unkown
HY-N2122 Neoisoliquiritin 99.74% Unkown
HY-N4089 Quercetin 3-gentiobioside Inhibitor 99.56% Unkown
HY-109070 Ralaniten Antagonist 99.57% Unkown
HY-117669 VPC-14228 Inhibitor 99.36% Unkown
HY-N2908 Atraric acid 99.97% Unkown
HY-145709 Ar-V7-IN-1 Inhibitor 98.02% Unkown
HY-112256 ACP-105 Modulator 98.92% Unkown
HY-114402 ARD-69 Degrader 99.61% Unkown
HY-132292 ARD-2128 Inhibitor 99.17% Unkown
HY-110028 Leelamine hydrochloride 98.10% Unkown
HY-70002S1 Enzalutamide-d6 Antagonist 99.85% Unkown
HY-N2673 5-Heptadecylresorcinol Activator 99.83% Unkown
HY-W013249 Boc-piperazine-benzoic acid 98.61% Unkown
HY-136242 UT-34 Degrader 98.09% Unkown
HY-102076 0990CL ≥98.0% Unkown
HY-108250 (R)-Bicalutamide Antagonist 99.95% Unkown
HY-112257 S-23 Modulator 99.63% Unkown
HY-141487 CLP-3094 Inhibitor 99.92% Unkown
HY-162412 PROTAC AR/AR-V7 degrader-1 99.72% Unkown
HY-164373 SC428 98.0% Unkown
HY-170329 PROTAC AR Degrader-8 99.98% Unkown
HY-N6703 ar-Turmerone Inducer 99.00% Unkown
HY-110060 NDT 9513727 Antagonist 99.35% Unkown
HY-117992 BR103 99.66% Unkown
HY-160020 ET516 Inhibitor 99.13% Unkown
HY-B1876 Nicosulfuron 97.27% Unkown
HY-N0475 Triptophenolide 99.98% Unkown
HY-19337 Ketodarolutamide Antagonist 98.72% Unkown
HY-125236 ZEN-3694 99.85% Unkown
HY-133020 ARD-266 Inhibitor 99.94% Unkown
HY-156111 ARD-1676 Degrader 98.05% Unkown
HY-139644 MIPS521 Agonist 98.21% Unkown
HY-101300 Cirazoline hydrochloride Agonist 99.56% Unkown
HY-103245 Cl-4AS-1 Agonist 99.64% Unkown
HY-147291 VPC-70063 99.92% Unkown
HY-18775 N6-(4-Hydroxybenzyl)adenosine 99.84% Unkown
HY-D1606 BODIPY FL prazosin Inhibitor 99.81% Unkown
HY-P10639 C5aR2 agonist P32 Agonist 99.17% Unkown
HY-16758 Verosudil Inhibitor 98.22% Unkown
HY-43962 CS-1-65 99.54% Unkown
HY-78542 Deshydroxyethoxy ticagrelor Inhibitor 98.82% Unkown
HY-B1421 Ractopamine hydrochloride Agonist 99.2% Unkown
HY-N5124 Meloside A Inhibitor 98.72% Unkown
HY-45219 ((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate 98.90% Unkown
HY-Y0261AS1 Ammonium sulphate,≥99.0%,AR-N152 99.30% Unkown
HY-18776 A2AR-agonist-1 Agonist 99.90% Unkown
HY-103180 2'-MeCCPA Agonist 99.80% Unkown
HY-103183 CV1808 Agonist ≥98.0% Unkown
HY-112895 UT-155 Antagonist 99.55% Unkown
HY-120208 MK204 Inhibitor 99.7% Unkown
HY-130992 Androgen receptor antagonist 1 Antagonist 99.64% Unkown
HY-147907 Adenosine receptor inhibitor 1 Inhibitor 98.29% Unkown
HY-149862 ARD-2051 Degrader 98.57% Unkown
HY-15844 AG-825 98.13% Unkown
HY-N7045 Isosilybin B 99.32% Unkown
HY-W077477 IHCH-7113 99.76% Unkown
HY-I0108 2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol oxalate 98.0% Unkown
HY-19319 MI-136 99.04% Unkown
HY-16985S Darolutamide-d4 Antagonist 98.58% Unkown
HY-103162 ANR94 Antagonist 98.91% Unkown
HY-119993 AR03 Inhibitor 99.1% Unkown
HY-122917 Danshenol A Inhibitor 99.67% Unkown
HY-126076A VPC-80051 99.77% Unkown
HY-171978A LM-189 free base Agonist 99.70% Unkown
HY-N0092S Inosine-2,8-d2 Agonist 99.69% Unkown
HY-N1731 2′-Hydroxy-5′-methoxyacetophenone Inhibitor 99.96% Unkown
HY-101393A CGP 12177 hydrochloride Modulator 99.69% Unkown
HY-108235A Lanicemine dihydrochloride Antagonist 99.92% Unkown
HY-117971 BVT173187 Inhibitor 99.97% Unkown
HY-120006A (rel)-AR234960 Agonist 98.95% Unkown
HY-131388 ABM-14 98.10% Unkown
HY-133045 VHL Ligand 8 98.10% Unkown
HY-139659 ARD-61 99.57% Unkown
HY-160777 VNPP433-3β 98.01% Unkown
HY-163340 GA32 Inhibitor 99.67% Unkown
HY-B0573S Propranolol-d7 hydrochloride Antagonist 98.47% Unkown
HY-B1866 Linuron Antagonist 99.88% Unkown
HY-E70333 Microgranulated pectolytic enzyme / Unkown
HY-N0378S2 D-Mannitol-13C6 99.96% Unkown
HY-N7043 Isosilybin A 99.51% Unkown
HY-113430 5-n-Heneicosylresorcinol Inhibitor 98.0% Unkown
HY-151239 ONT-993 Inhibitor 99.85% Unkown
HY-120018 VPC-13566 Inhibitor 99.92% Unkown
HY-12122A AR-C102222 hydrochloride Inhibitor 99.83% Unkown
HY-130845A AR antagonist 1 hydrochloride Antagonist 99.53% Unkown
HY-136596 Apalutamide-COOH 99.76% Unkown
HY-159639 BAY-2925976 Inhibitor 99.14% Unkown
HY-17042S1 Cetirizine-d8 Antagonist 96.46% Unkown
HY-B0846 Dimethomorph Inhibitor 99.10% Unkown
HY-N0138S1 Theobromine-d3 Inhibitor 99.78% Unkown
HY-135794S 11-Ketodihydrotestosterone-d3 Agonist ≥99.90% Unkown
HY-164552 ZNU-IMB-Z15 99.03% Unkown
HY-W877989 BWA-522 intermediate-1 99.27% Unkown
HY-148804 Vemtoberant Antagonist 98.03% Unkown
HY-N0378S3 D-Mannitol-2-13C 99.95% Unkown
HY-B0573BS Propranolol-d7 Antagonist ≥99.0% Unkown
HY-103246 TFM-4AS-1 99.96% Unkown
HY-111809 N6-Ethyladenosine Agonist 99.90% Unkown
HY-135483A AR-R17779 hydrochloride Agonist 99.0% Unkown
HY-135732 SK33 Antagonist 99.98% Unkown
HY-147545 A1AR antagonist 6 Antagonist 98.13% Unkown
HY-147908 Adenosine receptor inhibitor 2 Inhibitor 99.08% Unkown
HY-15011 L-372662 Antagonist 99.24% Unkown
HY-156084 LL-K9-3 99.2% Unkown
HY-161741 VinclozolinM2-2204 Degrader 98.00% Unkown
HY-162325 WJ-39 99.60% Unkown
HY-164807 SARD279 Degrader 96.04% Unkown
HY-168299 AR ligand-30 Ligand / Unkown
HY-169387 YT 6-2-PEG3-C2-NH2 Control 99.50% Unkown
HY-175231 ST171 Agonist 99.34% Unkown
HY-175652 AZD9750 Degrader 98.15% Unkown
HY-177094 Izicopan Antagonist / Unkown
HY-B0573S1 Propranolol-d7 (ring-d7) Antagonist 99.80% Unkown
HY-B1037S Salbutamol-d3 98.68% Unkown
HY-B1562B Bopindolol malonate 98.30% Unkown
HY-B1866S Linuron-d6 99.76% Unkown
HY-N0378S1 D-Mannitol-13C 99.9% Unkown
HY-P5123A Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg TFA Activator 98.75% Unkown
HY-Y0261AS Ammonium sulphate-d8 99.6% Unkown
HY-Y0827 Barium carbonate,AR,99% 99% Unkown
HY-76819 Benzyl (3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate 98.47% Unkown
HY-W017742 Rolapitant Intermediate 98.0% Unkown
HY-W341547 3,4-Dihydro-6,7-isoquinolinediol Agonist 98.71% Unkown
HY-W744625 Olodaterol-d3 hydrochloride 99.9% Unkown
HY-101039A AR-M 1000390 hydrochloride Agonist 98.20% Unkown
HY-101854 N6-(2-Phenylethyl)adenosine Agonist 99.41% Unkown
HY-103203 ST91 Agonist 99.75% Unkown
HY-123012A Lubabegron fumarate Antagonist 98.44% Unkown
HY-14250 PF-998425 Antagonist 98.63% Unkown
HY-147100 α1A-AR Degrader 9c Inhibitor 99.60% Unkown
HY-151604 Transketolase-IN-3 Inhibitor 98.94% Unkown
HY-162702 AZ'3137 Degrader 99.90% Unkown
HY-163940 LX1 99.13% Unkown
HY-17042S Cetirizine-d4 Antagonist 99.10% Unkown
HY-170820 XYD049 Inhibitor 99.46% Unkown
HY-171978 LM-189 Agonist 96.58% Unkown
HY-178259 α2AR agonist 2 Antagonist 99.46% Unkown
HY-179226 AP-7-168 Inhibitor 99.89% Unkown
HY-184126 JZY3221 Inhibitor 98.01% Unkown
HY-77734 AR-C133913XX 99.76% Unkown
HY-B1001A Todralazine hydrochloride Inhibitor 99.87% Unkown
HY-P1640 (Trp63,Trp64)​-​C3a(63-77) Agonist 99.23% Unkown
HY-RS00532 AKR1B1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-130845 AR antagonist 1 Antagonist 99.03% Unkown
HY-RS00884 Ar Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17235 Akr1b1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W110146 (3aS,4S,6aR)-Biotin-PEG4-Alkyne 99.93% Unkown
HY-111848 PROTAC AR Degrader-4 Inhibitor / Unkown
HY-111848A PROTAC AR Degrader-4 TFA Inhibitor 99.26% Unkown
HY-184124 JZY3032 Inhibitor / Unkown
HY-111372A (Rac)-Finerenone Antagonist 99.66% Unkown
HY-133127 AR453588 Activator 99.84% Unkown
HY-14249S Bicalutamide-d4 99.5% Unkown
HY-B1486S Oxprenolol-d7 hydrochloride Antagonist 98.25% Unkown
HY-101986A BIIE-0246 hydrochloride Antagonist 99.33% Unkown
HY-103177 PSB-10 hydrochloride Inhibitor 98.70% Unkown
HY-108449S Acoltremon-d3 99.58% Unkown
HY-111145 RD162 Antagonist 99.69% Unkown
HY-111372S1 Finerenone-d5 Antagonist 99.71% Unkown
HY-119996A AR-C141990 hydrochloride Inhibitor 98.2% Unkown
HY-123358 AR-H049020XX / Unkown
HY-12715S Yohimbine-13C,d3 Antagonist 99.0% Unkown
HY-14250A (Rac)-PF-998425 Antagonist 99.45% Unkown
HY-14296A PF-610355 (hydrochloride) Agonist / Unkown
HY-144127 AR antagonist 3 Antagonist 99.96% Unkown
HY-147261 B026 Inhibitor / Unkown
HY-151596 MAO-A/5-HT2AR-IN-1 Inhibitor 99.71% Unkown
HY-154959A (9R,12aR)-AZD4747 Control 98.90% Unkown
HY-16060S Apalutamide-d4 Antagonist 99.93% Unkown
HY-16060S1 Apalutamide-d3 / Unkown
HY-160887 FPT Agonist 98.06% Unkown
HY-162620 α2A-AR agonist 1 Agonist 99.92% Unkown
HY-168201 MJP6412 95.90% Unkown
HY-171048 GTx-027 Modulator 99.61% Unkown
HY-173703 β-Glu-PAB(CH2NH2)-Exatecan Substrate 99.60% Unkown
HY-176068 3-Cl-Pyridine-amide-acrylaldehyde-piperazine 99.30% Unkown
HY-176521A AR/BRD4 RIPTAC-1 TFA 99.61% Unkown
HY-179433 PROTAC AR Degrader-12 98.52% Unkown
HY-90009D (6S,12aR)-Tadalafil Inhibitor 99.48% Unkown
HY-B1037S3 Salbutamol-d9 acetate 99.48% Unkown
HY-B1114S Gliquidone-d6 99.42% Unkown
HY-D1379 Azophloxine 99.71% Unkown
HY-N0166R Gramine (Standard) 98.95% Unkown
HY-N0378S D-Mannitol-d8 99.86% Unkown
HY-N4232 Clematichinenoside AR Inducer 99.74% Unkown
HY-N7962 Cornoside Inhibitor 96.0% Unkown
HY-N9917 Galloylalbiflorin Antagonist 95.0% Unkown
HY-P5213 Vasopressin Dimer (parallel) TFA Activator 99.55% Unkown
HY-RS01751 C5AR2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W004425 DMPX Antagonist 99.66% Unkown
HY-W015061S N-(Phenylacetyl-d5)glycine ≥99.0% Unkown
HY-W653723 N-Nitrosodicyclohexylamine Antagonist 99.0% Unkown
HY-111372S Finerenone-d3 97.12% Unkown
HY-121837 β2AR-IN-15 Antagonist 98.84% Unkown
HY-133086 Hydrodolasetron 98.96% Unkown
HY-134555 A3AR antagonist 4 Antagonist 99.98% Unkown
HY-138089 17β-Hydroxy exemestane 98.21% Unkown
HY-16060S2 Apalutamide-13C,d3 Antagonist 99.90% Unkown
HY-400766 BWA-522 intermediate-2 99.87% Unkown
HY-B1037S2 Salbutamol-d9 98.42% Unkown
HY-RS21501 C3ar1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS29512 AP1AR Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W076756 4-Piperidyl N-(2-biphenyl)carbamate Antagonist 99.97% Unkown
HY-W157299 2-(Bromomethyl)-1-fluoro-3-methoxybenzene / Unkown
HY-Z7733 O-Desmethylcarvedilol Inhibitor 97.4% Unkown
HY-115282 JNJ-63576253 free base Antagonist / Unkown
HY-B1470S Azaperone-d4 Antagonist 95.83% Unkown
HY-N0092S1 Inosine-13C Agonist / Unkown
HY-101514 β3-AR agonist 1 Agonist / Unkown
HY-125839 OP-3633 Antagonist / Unkown
HY-133127A AR453588 hydrochloride Activator / Unkown
HY-148804A Vemtoberant mesylate Antagonist / Unkown
HY-183667 JNJ-pan-AR Inhibitor / Unkown
HY-N0138S Theobromine-d6 Inhibitor 98.0% Unkown
HY-100348R EPI-001 (Standard) / Unkown
HY-101039 AR-M 1000390 Agonist / Unkown
HY-101393 CGP 12177 Modulator / Unkown
HY-101986C BIIE-0246 dihydrochloride Antagonist / Unkown
HY-10275A Atecegatran TFA Inhibitor / Unkown
HY-103203A ST91 free base Agonist / Unkown
HY-103578 S-40503 Modulator / Unkown
HY-10512S AR-A014418-d3 Inhibitor / Unkown
HY-106388A Fadolmidine hydrochloride Agonist / Unkown
HY-106684A Ridazolol hydrochloride Antagonist / Unkown
HY-106769A (3aR,9aR)-Fluparoxan hydrochloride / Unkown
HY-106915 SG-210 Inhibitor / Unkown
HY-107018 AR-A 2 Antagonist / Unkown
HY-108235AS1 Lanicemine-d5 dihydrochloride Antagonist / Unkown
HY-108633 BYK 49187 Inhibitor / Unkown
HY-109139A Taminadenant mesylate Antagonist / Unkown
HY-110202 MRS5698 Agonist / Unkown
HY-111044 (+)-JNJ-37654032 Modulator / Unkown
HY-111231 CH4933468 Antagonist / Unkown
HY-111372B (R)-Finerenone Antagonist 99.70% Unkown
HY-112567 TRR469 Modulator / Unkown
HY-113526 AR-12463 / Unkown
HY-113701 CH5137291 Antagonist / Unkown
HY-113781 Ractopamine Agonist / Unkown
HY-113781S Ractopamine-d6 Agonist / Unkown
HY-115940 Aldose reductase-IN-2 Inhibitor / Unkown
HY-115977 Aldose reductase-IN-3 Inhibitor / Unkown
HY-116042 FSCPX Antagonist 99.94% Unkown
HY-116379 RS-100329 Antagonist / Unkown
HY-116982 BMY 7378 free base / Unkown
HY-117239 SB-206606 Agonist / Unkown
HY-117435 CIDD 0067106 Inhibitor / Unkown
HY-117527 L742791 Agonist / Unkown
HY-117781 GW-5823 Agonist / Unkown
HY-117953 RU 59063 Antagonist 98.61% Unkown
HY-118260 Phendioxan / Unkown
HY-118678 MRS1186 Antagonist / Unkown
HY-119088 Estrogen receptor modulator 12 Modulator / Unkown
HY-119170 BMS-779333 Antagonist / Unkown
HY-119436 LG-120907 Antagonist / Unkown
HY-119806 TMPPAA Agonist / Unkown
HY-119996 AR-C141990 Inhibitor / Unkown
HY-120090 MRS1177 Antagonist / Unkown
HY-120652 A3AR antagonist 3 Antagonist / Unkown
HY-12099 A3AR antagonist 2 Antagonist / Unkown
HY-121094 Androgen receptor allosteric antagonist 1 Antagonist / Unkown
HY-121588 IMTPPE Inhibitor / Unkown
HY-122048 AR-C67085 Antagonist / Unkown
HY-122108 Ilicicolin A Inducer / Unkown
HY-122231 MRS3558 Agonist / Unkown
HY-122963 Danshenol B / Unkown
HY-123059A (2S,3S)-Zenidolol hydrochloride Antagonist / Unkown
HY-123163 JNJ-1250132 / Unkown
HY-123308 VPC13163 Inhibitor / Unkown
HY-123310 JNJ-26146900 Antagonist / Unkown
HY-124270 Sibenadet hydrochloride Agonist / Unkown
HY-124412 Paynantheine Agonist / Unkown
HY-124585 Y08060 Inhibitor / Unkown
HY-125065 MK-4541 / Unkown
HY-125627 CP-394531 Antagonist / Unkown
HY-126464 Estromustine Modulator / Unkown
HY-12798CR AR-13503 (Standard) Inhibitor / Unkown
HY-12798E (R)-AR-13503 Control 98.20% Unkown
HY-128934 Antitumor agent-2 / Unkown
HY-129761 AR 17048 Activator / Unkown
HY-130190 Butopamine Activator / Unkown
HY-133044 Boc-Pip-alkyne-Ph-COOH / Unkown
HY-133046 VHL Ligand-Linker Conjugates 17 / Unkown
HY-133862 SCH-202676 99.46% Unkown
HY-13613S Dutasteride-13C6 / Unkown
HY-13613S2 Dutasteride-13C,15N,d / Unkown
HY-136960 β2AR antagonist 1 Antagonist / Unkown
HY-139046 MEPB Modulator / Unkown
HY-139694 hA3AR agonist 1 Agonist / Unkown
HY-139970 VPC-13789 Inhibitor / Unkown
HY-141865 Adenosine receptor antagonist 1 Antagonist / Unkown
HY-14249S1 (R)-Bicalutamide-d5 / Unkown
HY-142923 AR antagonist 2 Antagonist / Unkown
HY-14300AS Vilanterol-d4 trifenatate Agonist / Unkown
HY-14300D Vilanterol acetate Agonist / Unkown
HY-143471 WNY0824 / Unkown
HY-143535 HG122 / Unkown
HY-144115 A1AR antagonist 1 Antagonist / Unkown
HY-144116 A1AR antagonist 2 Antagonist / Unkown
HY-144672 A2A receptor antagonist 2 Antagonist / Unkown
HY-145308 Heterobivalent ligand-1 / Unkown
HY-145406 IHCH-3064 Inhibitor / Unkown
HY-145480 Silodosin Glucuronide sodium / Unkown
HY-145698 UCSF678 Agonist / Unkown
HY-145699 UCSF686 / Unkown
HY-145706 A2A/A1 AR antagonist-1 Antagonist / Unkown
HY-145862 5-HT6/5-HT2AR antagonist-1 Agonist / Unkown
HY-146026 Androgen receptor antagonist 3 Antagonist / Unkown
HY-146027 Androgen receptor antagonist 4 Antagonist / Unkown
HY-146397 TD-802 Degrader / Unkown
HY-146456 A1AR antagonist 3 Antagonist / Unkown
HY-146457 A3AR antagonist 1 Antagonist / Unkown
HY-146478 A1/A3 AR antagonist 1 Antagonist / Unkown
HY-146479 A1/A3 AR antagonist 2 / Unkown
HY-146494 Androgen receptor antagonist 5 Antagonist / Unkown
HY-146979 hA2A/hCA XII modulator 1 / Unkown
HY-147541 A2A/A3 AR antagonist-1 Antagonist / Unkown
HY-147543 A1AR antagonist 4 Antagonist / Unkown
HY-147544 A1AR antagonist 5 Antagonist / Unkown
HY-147585 C5aR-IN-1 / Unkown
HY-147586 C5aR-IN-2 / Unkown
HY-147587 C5aR-IN-3 / Unkown
HY-147706 AR524 / Unkown
HY-147875 Aldose reductase-IN-6 Inhibitor / Unkown
HY-148252 ADRA1D receptor antagonist 1 free base Antagonist / Unkown
HY-148300 AR-C66096 Antagonist / Unkown
HY-148361 Fluorogen binding modulator-1 / Unkown
HY-148524 β2AR/M-receptor agonist-1 / Unkown
HY-148525 PF-4348235 / Unkown
HY-148526 β2AR/M3-receptor agonist-1 Agonist / Unkown
HY-148533 β2AR agonist /M-receptor antagonist-1 / Unkown
HY-148777 A031 Degrader / Unkown
HY-149434 PROTAC AR-NTD degrader 1 Inducer / Unkown
HY-149727 β2AR agonist 2 Agonist / Unkown
HY-149728 β2AR agonist 3 Agonist / Unkown
HY-149914 WCA-814 Degrader / Unkown
HY-149916 A2AR-antagonist-1 Antagonist 96.68% Unkown
HY-150025 (4aS,8aR)-NPD-001 / Unkown
HY-150812 VHL Ligand 23 / Unkown
HY-150878 AR ligand-4 Ligand / Unkown
HY-151266 AR antagonist 4 Antagonist / Unkown
HY-151899 A3AR modulator 1 Agonist / Unkown
HY-152524 Androgen receptor antagonist 7 Antagonist / Unkown
HY-153157 MRS542 / Unkown
HY-153333 A1/A3 AR antagonist 3 Antagonist / Unkown
HY-153519 WWL0245 Inhibitor / Unkown
HY-153718 KI-ARv-03 Inhibitor / Unkown
HY-155183 A3AR agonist 1 Agonist / Unkown
HY-155184 A3AR agonist 2 Agonist / Unkown
HY-155543 Anticancer agent 135 Antagonist / Unkown
HY-155666 YXG-158 Degrader / Unkown
HY-155772 LUF7690 / Unkown
HY-156751 (Rac)-GDC-2992 Degrader / Unkown
HY-156983 MRS 5980 / Unkown
HY-157425 5-HT2CR agonist 1 Agonist / Unkown
HY-157429 25N-N1-Nap Agonist / Unkown
HY-157455 AR antagonist 5 / Unkown
HY-157796 β2AR agonist 4 Agonist / Unkown
HY-158057 A2AR/A2BR antagonist 1 Antagonist / Unkown
HY-158179 A3AR agonist 3 Agonist / Unkown
HY-158180 A3AR agonist 4 Agonist / Unkown
HY-158181 A3AR agonist 5 Agonist / Unkown
HY-159096 Apoptosis inducer 21 Inducer / Unkown
HY-159739 M17-B15 Inhibitor / Unkown
HY-159889 hA3AR agonist 2 Agonist / Unkown
HY-159922 AR antagonist 9 Antagonist / Unkown
HY-160221 PROTAC AR Degrader-7 / Unkown
HY-160262 PROTAC AR/BET protein degrader-1 Degrader / Unkown
HY-160547 PROTAC AR Degrader-5 Degrader / Unkown
HY-16060S3 Apalutamide-d7 Antagonist / Unkown
HY-160680 AR antagonist 6 Inhibitor / Unkown
HY-160692 AR antagonist 7 Antagonist / Unkown
HY-160777A VNPP433-3β dihydrochloride / Unkown
HY-160777B VNPP433-3β hydrochloride / Unkown
HY-161717 MRS5663 Agonist / Unkown
HY-161718 MRS8028 Agonist / Unkown
HY-161810 MRS8247 Modulator / Unkown
HY-161836 α2AR agonist 1 Agonist / Unkown
HY-162083 CB2R/5-HT1AR agonist 1 Agonist / Unkown
HY-162585 5-HT1AR agonist 1 Agonist / Unkown
HY-162659 β2AR ligand 1 / Unkown
HY-163363 β-AR antagonist 2 Antagonist / Unkown
HY-163378 C5aR1 antagonist 1 Antagonist / Unkown
HY-163379 C5aR1 antagonist 2 Antagonist / Unkown
HY-163485 AR antagonist 8 Inhibitor / Unkown
HY-163510 AR/AR-V7-IN-1 Inhibitor / Unkown
HY-163632 EGFR-IN-112 Inhibitor / Unkown
HY-163641 AR Degrader-1 Degrader / Unkown
HY-163813 AR Degrader-2 Degrader / Unkown
HY-163978 YGZ-331 Activator / Unkown
HY-165509 DU172 Ligand / Unkown
HY-167905 ATL444 Antagonist / Unkown
HY-168141 Androgen receptor antagonist 11 Antagonist / Unkown
HY-168168 (5aS,6R,6aR)-MK-8666 / Unkown
HY-168344 CACPD2011a-0001278239 Activator / Unkown
HY-168697 AR ligand-37 Ligand / Unkown
HY-169349 Androgen receptor antagonist 12 Antagonist / Unkown
HY-169385 ATC-324 Degrader / Unkown
HY-169386 YT 6-2 analog-1 Control 99.13% Unkown
HY-169388 YT 6-2 Control 98.15% Unkown
HY-169394 5-HT1AR agonist 2 / Unkown
HY-169967 AR ligand-31 / Unkown
HY-169975 tert-Butyl 4-(4-(piperazin-1-ylmethyl)piperidin-1-yl)benzoate / Unkown
HY-169976 E3 Ligase Ligand-linker Conjugate 140 / Unkown
HY-170303 AR ligand-32 Ligand / Unkown
HY-170304 E3 ligase Ligand 44 / Unkown
HY-170305 E3 Ligase Ligand-linker Conjugate 145 / Unkown
HY-170330 AR ligand-33 Ligand / Unkown
HY-17042AS1 Cetirizine-d8 dihydrochloride Antagonist 99.64% Unkown
HY-170448 PROTAC AR Degrader-9 / Unkown
HY-170449 E3 ligase Ligand 48 / Unkown
HY-170450 AR ligand-38 Ligand / Unkown
HY-170948 A2AR modulator-1 Modulator / Unkown
HY-170951 AR antagonist 10 Antagonist / Unkown
HY-171467 MRS7799 Antagonist / Unkown
HY-171808 ITRI-90 / Unkown
HY-171809 AR ligand 42 Ligand / Unkown
HY-172612 AR antagonist 13 Antagonist / Unkown
HY-172624 AR antagonist 14 Antagonist / Unkown
HY-172954 Androgen receptor ligand 1 / Unkown
HY-172956 E3 Ligase Ligand-linker Conjugate 188 / Unkown
HY-172995 RS130-180 Agonist / Unkown
HY-173044 5-HT1AR/5-HT6R ligand-1 / Unkown
HY-173045 5-HT5AR/5-HT6R ligand-1 Ligand / Unkown
HY-173372 PROTAC AR Degrader-10 Degrader / Unkown
HY-173373 AR ligand-39 Ligand / Unkown
HY-173409 AR antagonist 11 / Unkown
HY-173474 ERβ agonist-1 / Unkown
HY-173498 AR ligand 40 Antagonist / Unkown
HY-173559 AR antagonist 12 Antagonist / Unkown
HY-173635 Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB / Unkown
HY-173640 ID11916 / Unkown
HY-174157 AR493 Activator / Unkown
HY-174377 PeS-9 / Unkown
HY-174391 AR antagonist 15 Inducer / Unkown
HY-174413 A2AAR antagonist 3 Antagonist / Unkown
HY-174466 5-HT2AR ligand 1 / Unkown
HY-175178 Arrestin-3 modulator-1 Modulator / Unkown
HY-175285 5-HT2AR-IN-1 Inhibitor / Unkown
HY-175455 LYA914 / Unkown
HY-175456 AR-DBD ligand-1 / Unkown
HY-175669 ANO1-IN-5 Inhibitor / Unkown
HY-175790 AR/BET ligand-1 Ligand / Unkown
HY-175791 Ethyl-Cha-thalidomide-NH2 / Unkown
HY-175906 AR ligand-45 Ligand / Unkown
HY-175937 AR ligand-46 Ligand / Unkown
HY-175939 AR-V7 ligand-1 Ligand / Unkown
HY-175981 Paclitaxel-bromothiophene / Unkown
HY-176060 Platelet aggregation-IN-3 Ligand / Unkown
HY-176067 LO-4-25 Degrader / Unkown
HY-176128 BWA-6047 / Unkown
HY-176225 BY13 / Unkown
HY-17627S1 Avacopan-d4 Inhibitor / Unkown
HY-176714 VUF26034 Ligand / Unkown
HY-176717 5-HT1AR agonist 3 Agonist / Unkown
HY-176863 Di(5-(methylsulfonyl)-1,3,4-oxadiazol-2-yl)-benzene-amide-PEG4-ester-2,3,5,6-F-Ph / Unkown
HY-177670A Zintevir sodium Inhibitor / Unkown
HY-177694 PROTAC AR Degrader-11 Degrader / Unkown
HY-178030 CAXII-IN-3 / Unkown
HY-178148 AR antagonist 17 Antagonist / Unkown
HY-178413S D-Mannitol-d4 / Unkown
HY-178783 MRS8454 Modulator / Unkown
HY-178938 AR Degrader-3 / Unkown
HY-178998 5-HT7R antagonist 5 Antagonist / Unkown
HY-179050 Androgen receptor-IN-7 / Unkown
HY-179051 PSMA ligand 3 Ligand / Unkown
HY-179056 Psa-AR / Unkown
HY-179123 ZC9 / Unkown
HY-179124 Apoptosis inducer 52 / Unkown
HY-179248 Adenosine receptor antagonist 7 / Unkown
HY-179274 β2AR agonist 5 Agonist / Unkown
HY-179277 MIPS3526 Agonist / Unkown
HY-179367 AR-102 free acid / Unkown
HY-179442 AR ligand-48 / Unkown
HY-179605 AR ligand-49 Ligand / Unkown
HY-179671 A3AR antagonist 6 Antagonist / Unkown
HY-179681 A2A/A3 agonist-1 Agonist / Unkown
HY-179713 D2R/D3R/5-HT1AR agonist 1 Agonist / Unkown
HY-180409 YM580 Antagonist / Unkown
HY-180410 YM-1758735 Antagonist / Unkown
HY-180423 IRFI-165 Antagonist 98.0% Unkown
HY-180553 NSD2-IN-6 Inhibitor / Unkown
HY-181427 UT-143 Antagonist / Unkown
HY-181727 AR/AR-V7 degrader-1 / Unkown
HY-181877 IHCH-3185 / Unkown
HY-181970 XY25026 Inhibitor / Unkown
HY-181971 XY25028 Inhibitor / Unkown
HY-181977 RPI-GLYT2-82 Inhibitor / Unkown
HY-182331 WCF-598 / Unkown
HY-182432 A3AR antagonist-7 Antagonist / Unkown
HY-182687 MRS7469 Agonist / Unkown
HY-182714 N 0840 Antagonist / Unkown
HY-182722 UT-105 Degrader / Unkown
HY-182782 Analgesic agent-4 Ligand / Unkown
HY-182809 Androgen receptor degrader-6 / Unkown
HY-183239 A2AR/A2BR antagonist 2 Antagonist / Unkown
HY-183287 Androgen receptor antagonist-14 Antagonist / Unkown
HY-183357 GABAAR/5-HT2AR modulator-1 / Unkown
HY-183414 C5aR antagonist-1 Antagonist / Unkown
HY-183710 CDK9-IN-50 / Unkown
HY-183993 A3AR antagonist-8 Antagonist / Unkown
HY-184116 A2AR/EGFR-IN-1 / Unkown
HY-184195 PROTAC AR Degrader-13 / Unkown
HY-184680 β2AR agonist 6 / Unkown
HY-184681 β2AR agonist 7 / Unkown
HY-184896 XYD113 Inhibitor / Unkown
HY-184919 LMP2-IN-1 Inhibitor / Unkown
HY-184957 Androgen receptor antagonist 15 Antagonist / Unkown
HY-185003 α1A-AR ligand-1 Ligand / Unkown
HY-185786 CBP/p300-IN-25 / Unkown
HY-187083 9-Cyclopentyladenine / Unkown
HY-187229 HEMTAC AR degrader-1 Degrader / Unkown
HY-187369 AR antagonist 18 Antagonist / Unkown
HY-187536 SYA16263 / Unkown
HY-187537 5-HT2AR ligand-2 / Unkown
HY-187538 DR/5-HT7AR Ligand-1 Ligand / Unkown
HY-187560 VCU-1012 Agonist / Unkown
HY-19337S Ketodarolutamide-d3 Antagonist / Unkown
HY-19337S1 Ketodarolutamide-d6 Antagonist / Unkown
HY-19436A Solabegron hydrochloride Agonist / Unkown
HY-19532S ZM241385-d7 Antagonist / Unkown
HY-19682A Enciprazine dihydrochloride / Unkown
HY-400666 AR ligand-44 / Unkown
HY-400666A AR ligand-44 TFA / Unkown
HY-403733A (–)-JJ-450 Antagonist / Unkown
HY-403733B (+)-JJ-450 / Unkown
HY-403733C JJ-450 Antagonist / Unkown
HY-46286 TTFB Control 99.83% Unkown
HY-70006A Galeterone hydrochloride / Unkown
HY-77833 RU 56279 Antagonist 99.68% Unkown
HY-78542S Deshydroxyethoxy Ticagrelor-d7 / Unkown
HY-A0052S (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 / Unkown
HY-B0846S Dimethomorph-d8 / Unkown
HY-B1001 Todralazine Inhibitor / Unkown
HY-B1037B Salbutamol adipate / Unkown
HY-B1421S Ractopamine-d6 hydrochloride / Unkown
HY-B1421S1 Ractopamine-d9 hydrochloride / Unkown
HY-B1421S3 Ractopamine-d5 hydrochloride / Unkown
HY-B1486AS Oxprenolol-d7 Antagonist 98.05% Unkown
HY-B1562C Bopindolol fumarate / Unkown
HY-ER013S Sodium carbonate, AR, 99.8%-13C-1 / Unkown
HY-N0378AGL D-Mannitol, M200 (GMP Like) / Unkown
HY-N0378BGL D-Mannitol, M100 (GMP Like) / Unkown
HY-N0378S4 D-Mannitol-d2 / Unkown
HY-N0378S5 D-Mannitol-d1 / Unkown
HY-N0378S6 D-Mannitol-13C,d2 / Unkown
HY-N10906 (4R,4aS,5aS,6aR,6bS,7aR)-4-Hydroxy-3,6b-dimethyl-5-methylene-4,4a,5,5a,6,6a,7,7a-octahydrocyclopropa[2,3]indeno[5,6-b]furan-2(6bH)-one / Unkown
HY-N11163 (Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate / Unkown
HY-N15686 Torulene / Unkown
HY-N16722 (S)-ar-Turmerol / Unkown
HY-N17304 10S,13aR-Antofine N-oxide Substrate / Unkown
HY-N17604 (6aR,11aR)-Edunol / Unkown
HY-N3716 Dehydroglyasperin D Inhibitor / Unkown
HY-N6703S ar-Turmerone-d3 Inducer / Unkown
HY-N6883 6-Methoxytricin Inhibitor / Unkown
HY-P11007 β-catenin inhibitory peptoid Inhibitor / Unkown
HY-P11191 AR-23 Inhibitor / Unkown
HY-P1129 AR-M1896 Agonist / Unkown
HY-P11443 SRC2-2 peptide Ligand / Unkown
HY-P11476 (Z-AR)2Rh110 Substrate / Unkown
HY-P11660 β-catenin-IN-10 Inhibitor / Unkown
HY-P1345 TLQP-21 Agonist / Unkown
HY-P1345B [DArg10, DAla20] TLQP-21 / Unkown
HY-P1345C [DArg10, Aib20] TLQP-21 / Unkown
HY-P3477 Mca-PLA-Nva-Dap(Dnp)-AR-NH2 / Unkown
HY-P4931A Mca-KPLGL-Dap(Dnp)-AR-NH2 TFA / Unkown
HY-P5010 (D-Arg8)-Inotocin Antagonist / Unkown
HY-P5123 Arg-Glu(edans)-Ile-His-Pro-Phe-His-Pro-Phe-His-Leu-Val-Ile-His-Thr-Lys(dabcyl)-Arg Activator / Unkown
HY-P5214 Vasopressin Dimer (anti-parallel) TFA Activator / Unkown
HY-R01656 hsa-miR-548ar-3p mimic / Unkown
HY-R01656A hsa-miR-548ar-3p agomir / Unkown
HY-R01657 hsa-miR-548ar-5p mimic / Unkown
HY-R01657A hsa-miR-548ar-5p agomir / Unkown
HY-RI01656 hsa-miR-548ar-3p inhibitor / Unkown
HY-RI01656A hsa-miR-548ar-3p antagomir / Unkown
HY-RI01657 hsa-miR-548ar-5p inhibitor / Unkown
HY-RI01657A hsa-miR-548ar-5p antagomir / Unkown
HY-RS00883 AR Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS00885 Ar Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS00892 AREG Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01744 C3AR1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01750 C5AR1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03439 Cyp19a1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W041652 5-Hydroxypentanoic acid / Unkown
HY-W087006 p-Hydroxyphenylacetone Antagonist / Unkown
HY-W095672AS4 ((2S,7aR)-2-Fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol-d2 98.54% Unkown
HY-W1003189 E3 ligase Ligand 42 / Unkown
HY-W134312 Calcium citrate,AR,99% / Unkown
HY-W140282 Angiotensin II antipeptide Inhibitor / Unkown
HY-W192276 (±)-Desisopropylpropranolol Antagonist / Unkown
HY-W471937 α1B-AR antagonist 1 Antagonist / Unkown
HY-W707640 Salbutamol-d4 / Unkown
HY-W716464 Prochloraz-d7 / Unkown
HY-W742404 Bopindolol-d9 / Unkown
HY-W744741 Lupeol-d3 / Unkown
HY-W751275 Ractopamine-13C2 Agonist / Unkown
HY-W751276 Ractopamine-13C6 Agonist / Unkown
HY-W854844B JP-2-196 hydrochloride Degrader / Unkown
HY-W950003 (Rac)-Finerenone-d5 / Unkown
HY-W957364 Pomalidomide-C2-Br / Unkown
HY-100543R Zenidolol (Standard) / Unkown
HY-10064S1 Ticagrelor-d4 Antagonist / Unkown
HY-100661 Cetirizine Impurity D Antagonist / Unkown
HY-10122A (Rac)-Silodosin Inhibitor / Unkown
HY-10122S Silodosin-d4 Antagonist / Unkown
HY-101479S Iclaprim-d6 Inhibitor / Unkown
HY-101977B (3aR)-Selitrectinib Inhibitor / Unkown
HY-10275 Atecegatran Inhibitor / Unkown
HY-103163 (±)-5'-Chloro-5'-deoxy-ENBA Agonist / Unkown
HY-106178D PMX 53 monoacetate / Unkown
HY-106684 Ridazolol Antagonist / Unkown
HY-106769B (3aR,9aR)-Fluparoxan / Unkown
HY-111206 β3-AR agonist 3 Agonist / Unkown
HY-111273 AR244555 Antagonist / Unkown
HY-112006 (S)-ar-Curcumene / Unkown
HY-114246 Varilutamide / Unkown
HY-114602 AR-C117977 Inhibitor / Unkown
HY-115862 Benzo[c][1,8]naphthyridin-6(5H)-one Inhibitor / Unkown
HY-116065 CUMI-101 Agonist / Unkown
HY-116508 MK 319 Inhibitor / Unkown
HY-118375 Phenylbutyl isoselenocyanate Inducer / Unkown
HY-118944 L-748328 Antagonist / Unkown
HY-12122 AR-C102222 Inhibitor / Unkown
HY-122053 Amidephrine hydrochloride Inhibitor / Unkown
HY-122177 MK181 Inhibitor / Unkown
HY-124259 I-AB-MECA Ligand / Unkown
HY-125602 MNI-444 / Unkown
HY-131953 Androgen receptor-IN-3 Inhibitor / Unkown
HY-136702 L-97-1 Antagonist / Unkown
HY-13715S (Rac)-Norepinephrine-d3 formate / Unkown
HY-139444 AR ligand-51 Ligand / Unkown
HY-14300S2 Vilanterol-d12 Agonist / Unkown
HY-155467 MRS7935 Modulator / Unkown
HY-15746S (rac)-Dobutamine-d4 hydrochloride Agonist / Unkown
HY-15746S1 (rac)-Dobutamine-d6 hydrochloride Agonist / Unkown
HY-158882 FLAC6 / Unkown
HY-159929 Antibiotic adjuvant 2 Inhibitor / Unkown
HY-159930 Antibiotic adjuvant 3 Inhibitor / Unkown
HY-162851 Adenosine receptor agonist 1 Agonist / Unkown
HY-164371 (+)-JJ-74-138 Antagonist / Unkown
HY-164477 FL442 Modulator / Unkown
HY-164621 A3AR antagonist 5 Antagonist 98.17% Unkown
HY-166478S O-Desmethyl carvedilol-d5 Inhibitor / Unkown
HY-166876S Nicergoline impurity 18-d4 / Unkown
HY-166887S Tiotropium bromide impurity-d3 / Unkown
HY-166898S trans Nonachlor-13C10 / Unkown
HY-166906S cis-Nonachlor-13C10 / Unkown
HY-168296 AR ligand-29 / Unkown
HY-168384 M04 / Unkown
HY-168547S AR89-d6 Inhibitor / Unkown
HY-169966 Boc-CH2-O-(CH2)4-OTs / Unkown
HY-170784 TKL-IN-1 Inhibitor / Unkown
HY-172730 2,2,3,3,4,4,5,5,5-Nonafluoro-N-(2-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)ethyl)pentanamide / Unkown
HY-172955 E3 ligase Ligand 65 / Unkown
HY-175457 AR-DBD ligand-Linker Conjugate 1 / Unkown
HY-176129 AR ligand 41 Ligand / Unkown
HY-176759 AR-102 isopropyl ester Agonist / Unkown
HY-180455 AR ligand-50 Ligand / Unkown
HY-184865 Anticancer agent 340 / Unkown
HY-19346 AR-13324 analog mesylate 98.0% Unkown
HY-19436S Solabegron-d8 Agonist / Unkown
HY-19506 AR-709 Inhibitor / Unkown
HY-19682 Enciprazine / Unkown
HY-401056 BWA-522 intermediate-3 / Unkown
HY-B0845R Prochloraz (Standard) / Unkown
HY-B1276S Metaproterenol-d7 hemisulfate Agonist / Unkown
HY-B1421S2 Ractopamine-d3 hydrochloride Agonist 98.30% Unkown
HY-N0092S4 Inosine-13C3 Agonist / Unkown
HY-N0166S Gramine-d2 / Unkown
HY-N0819R Raddeanin A (Standard) Inducer / Unkown
HY-N13308 8-Hydroxy-ar-turmerone / Unkown
HY-N6703A (R)-ar-Turmerone / Unkown
HY-N8504 Neoaureothin / Unkown
HY-P10639A C5aR2 agonist P32 acetate Agonist / Unkown
HY-RS17019 Areg Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18377 C5ar1 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19897 Fdxr Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24857 C5ar1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26398 Fdxr Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS28019 C3ar1 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W069173 2-Thioadenosine Ligand 96.73% Unkown
HY-W093399S Ammonium bicarbonate-15N Inhibitor / Unkown
HY-W130878 4-Octylphenol Activator / Unkown
HY-W353622 2,5-Dioxopyrrolidin-1-yl 4-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)butanoate / Unkown
HY-W654262 10α-Methoxy-9,10-dihydrolysergol-d3 / Unkown
HY-W702056 DMTr-Biotin-C6-CE phosphoramidite / Unkown
HY-W728110 5-MeO-pyr-T Agonist / Unkown
HY-W741999 Metaproterenol-d7-1 hemisulfate Agonist / Unkown
HY-W743954 Nicergoline impurity 11-d3 / Unkown
HY-U00391 β3-AR agonist 2 Agonist / Unkown
Inhibitory Antibodies (7)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991748 Anti-Human/Mouse Amphiregulin Antibody (AR37) Inhibitor 99.544% Unkown
HY-P990188 Anti-Mouse MHC class II (I-A) Antibody (Y-3P) 98.852% Unkown
HY-P990324 Anti-AA2AR/Adenosine A2aR Antibody (3F6-9G5) Inhibitor ≥99.0% Unkown
HY-P991485 Anti-CD88/C5AR1 Antibody (G2_anti-C5aR) Inhibitor / Unkown
HY-P990186 Anti-Mouse MHC Class II (I-Ak, I-Ar, I-Af, I-As,I-Ag7) Antibody (10-3.6.2) / Unkown
HY-P991318 AR20.5 Inhibitor / Unkown
HY-P991796 Anti-Mouse C5aR Antibody (20/70) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens AR NCBI NCBI:367